DA4-JC

DA4-JC has been studied in 1 paper since 2021: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 1, 2021: “A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease”.

Intervention

1 paper studies it5 findingsUpdated

More peptides

See all 1 papers on DA4-JC

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Animals1

What did studies of DA4-JC find?

5

Studies of DA4-JC measured 5 outcomes, among them mitophagy, amyloid and Synapses.

Mitophagy

upin mice1

1 study
  1. DA4-JC activates mitophagy in mice (PINK1-Parkin signaling).

    “improving the phosphatase and tensin homologue induced putative kinase 1 (PINK1) - Parkin mitophagy signaling pathway”

    AnimalsPINK1-Parkin signaling

    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease

    Journal of Alzheimer's disease : JAD

More on Mitophagy

Amyloid

downin mice1

1 study
  1. DA4-JC decreases amyloid in APP/PS1/tau mice.

    “downregulating amyloid, p-tau, and autophagy marker P62 levels”

    Animalsin APP/PS1/tau mice

    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease

    Journal of Alzheimer's disease : JAD

More on Amyloid

Synapses

upin mice1

1 study
  1. DA4-JC increases synapses in APP/PS1/tau mice.

    “increased numbers of synapses and dendritic spines”

    Animalsin APP/PS1/tau micehippocampus

    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease

    Journal of Alzheimer's disease : JAD

long-term potentiation

upin mice1

1 study
  1. DA4-JC increases long-term potentiation in APP/PS1/tau mice.

    “enhanced LTP in the hippocampus”

    Animalsin APP/PS1/tau micehippocampus

    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease

    Journal of Alzheimer's disease : JAD

Cognitive impairment

downin mice1

1 study
  1. DA4-JC decreases cognitive impairment in APP/PS1/tau mice.

    “DA4-JC improved cognitive impairment in a range of tests”

    Animalsin APP/PS1/tau mice

    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease

    Journal of Alzheimer's disease : JAD

Latest